What Exactly is Chemotherapy?

Chemotherapy for dogs is the use of drugs that kill or slow cancer cells throughout the body, rather than treating one spot the way surgery or radiation does. It is used when cancer has spread, when it is likely to spread, or when the cancer type is one that lives in the bloodstream and lymph system and cannot be cut out at all.

The single most important thing to understand is that veterinary chemotherapy is not aiming for the same thing human chemotherapy aims for. In people, oncologists often accept severe short-term suffering in exchange for a chance at cure. In dogs, that trade is rarely considered acceptable. The stated goal in current veterinary guidelines is tumor control while maintaining or improving the patient's quality of life (Christensen et al., 2026). Protocols are built around that priority, which is why most dogs on chemotherapy carry on being recognizably themselves.

The numbers back this up. Roughly 15 to 30 percent of dogs experience side effects, most of them mild and manageable, and severe events requiring hospitalization occur in about 5 to 7 percent (Christensen et al., 2026).

Key points 

• Most dogs tolerate chemotherapy well. In an owner survey of dogs receiving palliative chemotherapy for lymphoma, most owners rated their dog's quality of life as good during treatment and did not regret the decision (Mellanby et al., 2003).
• Hair loss is uncommon in dogs and mostly affects breeds with continuously growing coats such as Poodles, Scottish Terriers, and West Highland White Terriers (Christensen et al., 2026).
• There are three broad approaches: conventional chemotherapy given at intervals, metronomic chemotherapy given daily at home in low doses, and targeted drugs that block specific cancer signaling pathways.
• The main dose-limiting problem is a drop in white blood cells, usually around a week after treatment. This is why bloodwork is checked even when your dog looks completely fine.
• Fever in a dog on chemotherapy is an emergency, not a wait-and-see.
• Appetite loss is one of the most common reasons owners stop treatment early, and it is usually fixable if reported quickly (Christensen et al., 2026).
• Owners get this wrong in both directions. In one survey, 58 percent said they would decline chemotherapy for a pet based largely on their impression of side effects, while 72 percent overestimated survival time and many expected remission or cure (Williams et al., 2017).
• There are real safety precautions for your household, mostly involving your dog's waste for about 72 hours after treatment.

Detailed explanation

The picture in your head is probably a human cancer ward

Almost everyone arrives at this conversation with an image already loaded: someone they loved, exhausted, nauseated, losing their hair. That image is doing a lot of work, and it is worth naming.

A survey of dog and cat owners found that 58 percent would not choose chemotherapy for a pet, largely because of what they believed the side effects would be, and that inappetence, weight loss, and low mood were rated as unacceptable side effects (Williams et al., 2017). The same survey found that 72 percent overestimated how long chemotherapy would extend a pet's life, with many believing it would produce remission or cure.

Both of those are worth correcting, and they pull in opposite directions. Dogs generally feel considerably better on chemotherapy than people expect. And chemotherapy generally buys less time than people hope. Holding both of those at once is the accurate position.

There is a related finding worth knowing. When researchers surveyed 152 pet owners and 111 veterinary oncologists about acceptable side effects, the two groups weighed things differently. Oncologists accepted higher-grade side effects when the goal was cure or life extension, while owners accepted higher-grade side effects when the goal was improving quality of life, and owners overall accepted greater risk of moderate or serious events (Leonardi et al., 2024). If you and your veterinarian seem to be valuing different things, that is a documented pattern rather than a failure of communication. Say what matters most to you out loud.

What chemotherapy actually is, in three flavors

Conventional chemotherapy  is what most people mean by the word. Drugs are given at the highest dose the patient tolerates, aimed at rapidly dividing cells, with recovery gaps between treatments so that normal fast-dividing tissues like bone marrow and gut lining can repair. Treatments typically fall somewhere between weekly and every three weeks (Christensen et al., 2026). This is the approach used for lymphoma and leukemia, and after surgery for cancers that spread readily, such as osteosarcoma, hemangiosarcoma, and high-grade mast cell tumors.

Metronomic chemotherapy  is different in shape. Low doses of an oral drug are given daily or every other day at home, usually alongside an anti-inflammatory, and the target is the tumor's blood supply rather than the tumor cells directly. The goal is stabilizing disease rather than shrinking it. Side effects are generally mild, administration is easy, and costs are lower (Christensen et al., 2026). It is often considered when conventional protocols have stopped working or when an owner declines them.

Be aware that the evidence base here is thinner than for conventional protocols. The guidelines note real gaps in knowledge about which cancers suit this approach best and how to judge whether it is working (Christensen et al., 2026). Most published studies are early-phase trials, concentrated in hemangiosarcoma, soft tissue sarcoma, and bladder cancer.

Targeted therapy  uses drugs that block specific signaling pathways cancer cells depend on. In dogs the main example is a tyrosine kinase inhibitor given as a daily tablet, currently approved for certain recurrent mast cell tumors and used beyond that indication for a range of other tumors (Christensen et al., 2026). These require monitoring of bloodwork, weight, blood pressure, and urine protein, because their side effect profile is different from conventional chemotherapy.

Immunotherapy, including vaccines and antibody treatments, is a separate category rather than a type of chemotherapy, though it is often discussed in the same appointment.

Why it is used, and what it is honestly trying to achieve

Chemotherapy in dogs is used in three main situations.

For cancers of the blood and lymphatic system, such as lymphoma, it is the primary treatment. There is nothing to cut out.

After surgery, it is used to slow microscopic disease that has already spread but cannot yet be seen. This is called adjuvant treatment, and it is why a dog whose chest X-rays looked clear may still be advised to have chemotherapy. Clear imaging rules out visible spread, not microscopic spread.

Before surgery, occasionally, to shrink a tumor that responds to drugs so that the operation becomes more feasible.

What it is usually not doing is curing the cancer. Veterinary chemotherapy is largely about disease control, extending good time, and keeping a dog comfortable. Some dogs achieve durable remissions. Very few are cured. If your veterinarian talks in medians and ranges rather than promises, that is honesty rather than evasion.

What a chemotherapy day actually looks like

Most protocols are outpatient. You drop your dog off or wait, and the visit typically runs a couple of hours rather than all day.

A credentialed veterinary technician takes a history covering all current medications and supplements, diet, and how your dog has been since the last visit. Vital signs are taken. Bloodwork is run to confirm your dog's counts are high enough to treat. Doses are calculated by body surface area, and guidelines recommend two people independently calculate every dose before it is given, because the arithmetic matters and the margin for error is narrow (Christensen et al., 2026).

For injectable drugs, a clean intravenous catheter is placed. Several common chemotherapy drugs are vesicants, meaning they damage tissue if they leak outside the vein, so the drug is given by hand rather than by pump and your dog is monitored throughout (Christensen et al., 2026).

Then you go home, usually with anti-nausea medication and often with appetite support. Guidelines specifically recommend that patients go home with medications to use if side effects appear after hours, so that you can act rather than wait (Christensen et al., 2026). If you are not offered these, ask.

Side effects, with the actual numbers

The tissues most affected by conventional chemotherapy are the ones that divide fastest: bone marrow, hair follicles, and the lining of the gut.

Bone marrow suppression is the main dose-limiting problem. Low neutrophils, a type of white blood cell, is the specific concern, and the guidelines identify it as the primary dose-limiting toxicity in veterinary oncology (Christensen et al., 2026). The lowest point, called the nadir, usually falls around a week after treatment, though it varies by drug. This is why your dog gets bloodwork on a day when nothing appears to be wrong. A dog can look entirely normal and have a neutrophil count that requires delaying the next treatment.

The number that matters is the neutrophil count, not the total white cell count. If your dog is afebrile and feeling well, low counts are usually managed at home. If there is fever alongside low counts, that is febrile neutropenia, which the guidelines classify as an oncologic emergency requiring hospitalization (Christensen et al., 2026). Take a temperature at home if your dog seems off during the week after treatment, and call rather than wait.

Hair loss is genuinely uncommon in dogs, and this surprises people more than anything else. It occurs mainly in breeds with continuously growing coats, including Poodles, Scottish Terriers, and West Highland White Terriers. Shaved patches from catheters or ultrasound may regrow slowly. When hair does regrow, it sometimes comes back a different color or texture (Christensen et al., 2026).

Gastrointestinal upset is the side effect owners actually encounter. Vomiting, diarrhea, nausea, and reduced appetite typically last around three days and usually resolve with supportive medication (Christensen et al., 2026). Different drugs carry different risk levels, and your veterinarian should tell you which category your dog's protocol falls into.

Drug-specific effects  exist too. Some drugs have a cumulative limit because of heart effects. One can irritate the bladder lining. Some are used cautiously in breeds carrying the MDR1 genetic variant, which affects how certain drugs are cleared, including many herding breeds. Ask specifically what your dog's drugs carry.

Appetite loss deserves its own paragraph

One of the most common reasons owners stop chemotherapy prematurely is that their dog goes off food (Christensen et al., 2026). It is distressing in a way that is hard to overstate, because feeding a dog is one of the main ways we care for them, and a dog turning away from a bowl feels like a verdict.

It usually is not one. Nausea is often the underlying driver, and it responds to medication. The guidelines urge owners to report even mild changes in eating so that support can start early, because addressing it quickly keeps dogs on treatment and improves how they feel throughout (Christensen et al., 2026).

Practical measures that help: small frequent meals, varying texture, warming food, and starting anti-nausea or appetite medication at the first sign rather than the third day. If appetite remains a problem, adjusting the protocol or delaying a treatment often solves it without abandoning the plan entirely.

Safety in your own house 

This part is usually underexplained, and it matters.

Chemotherapy drugs are classified as hazardous drugs. Exposure risk does not stop when your dog leaves the clinic, because the drugs are excreted in urine and feces. Current guidance for owners is to avoid contact with your dog's waste for 72 hours after treatment, and to wear gloves and a mask if handling it is unavoidable. Oral chemotherapy tablets should never be split or crushed, should be handled with gloves, and should not be handled in areas where food is stored or prepared. Compounded liquid versions are available but are not recommended because of exposure risk (Christensen et al., 2026).

Anyone in the household who is pregnant, trying to conceive, breastfeeding, or immunocompromised should not handle these drugs or the waste at all.

None of this means your dog is dangerous to cuddle. It means specific handling precautions for specific materials over a defined window.

Extralabel use is normal and not a warning sign

Most chemotherapy drugs used in dogs were developed and approved for humans, and are used in animals extralabel. Even veterinary-approved cancer drugs are commonly used for tumour types outside their labelled indication, based on published evidence and clinical experience (Christensen et al., 2026).

This sometimes alarms owners who read a drug insert written for people. It should not. It is the normal structure of veterinary oncology, and it is legal and evidence-guided.

The cost conversation

Chemotherapy is expensive, and cost is the single biggest reason owners do not pursue cancer treatment. In a survey of board-certified veterinary oncologists, 83 percent identified cost as the largest barrier for their clients (Johannes & Sones, 2025).

Ask for the full expected cost of a protocol, not the per-visit figure, and ask what the monitoring bloodwork adds. Ask whether a less intensive protocol, a single-agent approach, or metronomic therapy would be reasonable alternatives at a lower cost. These are legitimate options rather than second-class ones, and a good oncology conversation will present them without you having to force it.

How to think about deciding

The evidence from owners who have actually been through it is reassuring but not unanimous. In one survey of owners of dogs receiving palliative chemotherapy for lymphoma, many dogs experienced treatment complications, yet most owners felt their dog's quality of life was good during treatment and had no regrets about their decision (Mellanby et al., 2003).

The useful questions are concrete. What is this protocol realistically expected to achieve, in median terms. How many visits, over how many weeks. What will my dog most likely experience. What will I have to do at home. What happens if we do nothing beyond comfort care.

And one more that owners rarely ask: what would make us stop. Deciding in advance what an unacceptable quality of life looks like is far easier before you are in the middle of it, and it protects both you and your dog from drifting past a line you would not have chosen to cross.

When to contact a veterinarian

Contact your veterinary team promptly if your dog:

• Develops a fever or feels hot, is unusually lethargic, or seems unwell during the week after treatment. Combined with low white cell counts, fever is an emergency.
• Stops eating or eats noticeably less. Report this early rather than waiting to see if it passes.
• Vomits repeatedly, has diarrhea lasting more than about a day, or cannot keep water down.
• Has blood in the urine, strains to urinate, or urinates more frequently.
• Develops swelling, pain, redness, or blistering at the site where an intravenous drug was given, even days later.
• Seems weak, has pale gums, or collapses. This warrants emergency care immediately.
• Is due for treatment and has been off color in the days beforehand. Say so before the drug goes in rather than after.

Also call if you cannot manage the medication schedule or the cost. Adjustments are usually possible, and stopping quietly is the worst version of that decision.

Questions to ask your veterinarian 

• What is the goal of chemotherapy for my dog specifically: control, extending time, or comfort?
• Which protocol are you recommending, how many visits, and over how long?
• What are the most likely side effects with these particular drugs, and when would they appear?
• Will my dog need bloodwork between treatments, and what happens if the counts are low?
• What medications will I have at home in case side effects start after hours?
• Are there lower-cost or less intensive options that would still be reasonable here?
• What precautions do I need to take at home, and for how long after each treatment?
• Does my dog's breed or any existing condition change which drugs are safe?
• What would make you recommend stopping or changing the plan?

Sources 

Christensen, J., Johnson, K., Ettinger, S., Garrett, L., Gordon, I., Ireifej, S., Love, A., & Wisecup, M. (2026). AAHA oncology guidelines for dogs and cats. Journal of the American Animal Hospital Association, 62 (1), 1–37. https://doi.org/10.5326/JAAHA-MS-7549 

Johannes, C. M., & Sones, E. (2025). The future of veterinary oncology: What is financially sustainable? Today's Veterinary Practice , July/August 2025. https://todaysveterinarypractice.com/oncology/the-future-of-veterinary-oncology-what-is-financially-sustainable/

Leonardi, A. J., Fulkerson, C. M., & Shields, C. G. (2024). Veterinary oncologists and pet owners differ in their perceptions of chemotherapy-related adverse events in cancer-bearing dogs. Journal of the American Veterinary Medical Association, 262 (3). https://doi.org/10.2460/javma.23.09.0496 

Mellanby, R. J., Herrtage, M. E., & Dobson, J. M. (2003). Owners' assessments of their dog's quality of life during palliative chemotherapy for lymphoma. Journal of Small Animal Practice, 44 (3), 100–103. https://doi.org/10.1111/j.1748-5827.2003.tb00127.x

Williams, J., Phillips, C., & Byrd, H. M. (2017). Factors which influence owners when deciding to use chemotherapy in terminally ill pets. Animals, 7 (3), 18. https://doi.org/10.3390/ani7030018